Theravance Biopharma, Inc. (TBPH)
16.10
+0.08
(+0.50%)
USD |
NASDAQ |
Apr 06, 16:00
16.10
0.00 (0.00%)
After-Hours: 20:00
Theravance Biopharma Shareholders Equity (Quarterly) : 296.72M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Integer Holdings Corp. | 1.747B |
| QuidelOrtho Corp. | 1.920B |
| Catalyst Pharmaceuticals, Inc. | 954.27M |
| Viatris, Inc. | 14.71B |
| Nektar Therapeutics | 89.83M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 485.57M |
| Total Liabilities (Quarterly) | 188.85M |
| Debt to Equity Ratio | 0.2544 |
| Current Ratio | 10.93 |
| Net Debt Paydown Yield | -0.64% |